533 related articles for article (PubMed ID: 34560422)
1. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
[TBL] [Abstract][Full Text] [Related]
2. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis.
Vadevoo SMP; Kang Y; Gunassekaran GR; Lee SM; Park MS; Jo DG; Kim SK; Lee H; Kim WJ; Lee B
Theranostics; 2024; 14(6):2605-2621. PubMed ID: 38646639
[No Abstract] [Full Text] [Related]
3. IL4 Receptor-Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity.
Vadevoo SMP; Kim JE; Gunassekaran GR; Jung HK; Chi L; Kim DE; Lee SH; Im SH; Lee B
Mol Cancer Ther; 2017 Dec; 16(12):2803-2816. PubMed ID: 28878029
[TBL] [Abstract][Full Text] [Related]
4. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes.
Moradi-Chaleshtori M; Bandehpour M; Soudi S; Mohammadi-Yeganeh S; Hashemi SM
Cancer Immunol Immunother; 2021 May; 70(5):1323-1339. PubMed ID: 33140190
[TBL] [Abstract][Full Text] [Related]
6. Ferroptotic cardiomyocyte-derived exosomes promote cardiac macrophage M1 polarization during myocardial infarction.
Sun S; Wu Y; Maimaitijiang A; Huang Q; Chen Q
PeerJ; 2022; 10():e13717. PubMed ID: 35818358
[TBL] [Abstract][Full Text] [Related]
7. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
[TBL] [Abstract][Full Text] [Related]
8. In Situ Reprogramming of Tumor-Associated Macrophages with Internally and Externally Engineered Exosomes.
Zhang L; Lin Y; Li S; Guan X; Jiang X
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217089. PubMed ID: 36658634
[TBL] [Abstract][Full Text] [Related]
9. BMSCs-derived Exosome CISH Alleviates Myocardial Infarction by Inactivating the NF-κB Pathway to Stimulate Macrophage M2 Polarization.
Ouyang M; Yang Y; Yu G; Zhao J; Peng Y
Cardiovasc Toxicol; 2024 Apr; 24(4):422-434. PubMed ID: 38512651
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer.
Chen Y; Gong L; Cao Y; Liu Z; Wang Y; Cheng H; Feng Y; Yao S; Yin Y; Wu Z; Huang Z
J Control Release; 2024 Feb; 366():395-409. PubMed ID: 38184235
[TBL] [Abstract][Full Text] [Related]
11. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
12. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.
Kim H; Park HJ; Chang HW; Back JH; Lee SJ; Park YE; Kim EH; Hong Y; Kwak G; Kwon IC; Lee JE; Lee YS; Kim SY; Yang Y; Kim SH
Bioact Mater; 2023 Jul; 25():527-540. PubMed ID: 37056267
[TBL] [Abstract][Full Text] [Related]
13. Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages.
Moradi-Chaleshtori M; Shojaei S; Mohammadi-Yeganeh S; Hashemi SM
Life Sci; 2021 Oct; 282():119800. PubMed ID: 34245773
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer.
Zhao Y; Zheng Y; Zhu Y; Li H; Zhu H; Liu T
J Nanobiotechnology; 2022 Aug; 20(1):359. PubMed ID: 35918698
[TBL] [Abstract][Full Text] [Related]
15. Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From
Zhu S; Lu J; Lin Z; Abuzeid AMI; Chen X; Zhuang T; Gong H; Mi R; Huang Y; Chen Z; Li G
Front Oncol; 2022; 12():870528. PubMed ID: 35600340
[No Abstract] [Full Text] [Related]
16. Mesenchymal stem cell exosomal tsRNA-21109 alleviate systemic lupus erythematosus by inhibiting macrophage M1 polarization.
Dou R; Zhang X; Xu X; Wang P; Yan B
Mol Immunol; 2021 Nov; 139():106-114. PubMed ID: 34464838
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
18. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Jang JY; Lee JK; Jeon YK; Kim CW
BMC Cancer; 2013 Sep; 13():421. PubMed ID: 24044575
[TBL] [Abstract][Full Text] [Related]
19. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
20. Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization.
Dong B; Wang C; Zhang J; Zhang J; Gu Y; Guo X; Zuo X; Pan H; Hsu AC; Wang G; Wang F
Stem Cell Res Ther; 2021 Mar; 12(1):204. PubMed ID: 33761997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
